- Abbott hit by cyberattack on cancer diagnostics, LabCentral portal businessesAbbott has been struck by several cyberattacks which targeted the medtech giant’s cancer diagnostics and LabCentral businesses. <br>Fierce Biotech · 9d ago↗ source
- Opinion: Beware the unintended consequences of testosterone screening for military servicemembers“I fear that the widespread rollout of testosterone screening may lead to some surprising and unintended consequences,” writes a urologist who studies testosterone.STAT · 9d ago↗ source
- ‘A rising tide scenario’: Why other Big Pharmas could follow Lilly into psychedelicsAfter Eli Lilly dived into the psychedelics space with a $2.8 billion upfront acquisition of AtaiBeckley last week, industry experts told Fierce that the deal would give the space added momentum.